RTI International is one of the world’s leading research institutes, dedicated to improving the human condition by turning knowledge into practice. Our staff of more than 3,700 provides research and technical services to governments and businesses in more than 75 countries in the areas of health and pharmaceuticals, education and training, surveys and statistics, advanced technology, international development, economic and social policy, energy and the environment, and laboratory testing and chemical analysis.
RTI is a global leader in integrated preventive chemotherapy (PC) for NTD control. Since 2006, RTI has worked with US Agency for International Development (USAID) support in partnership with NTD endemic countries in Africa, Asia, Latin America and the Carribbean to integrate and expand their national NTD control programs for lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminths, and trachoma. RTI has expertise in integrated NTD control program management and implementation, integrated strategic planning and costing, disease mapping, surveillance, and monitoring and evaluation (M&E). In addition, RTI contributes to the global policy dialogue on integrated NTD control, participating in multiple World Health Organization (WHO) Advisory and Working Groups on NTDs.